HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cavernous Transformation Of Portal Vein

Idiopathic extrahepatic portal hypertension (EHPH) due to cavernous transformation of the portal vein. OMIM: 601004
Also Known As:
Portal Vein, Cavernous Transformation Of
Networked: 12 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Portal Hypertension
2. Hemorrhage
3. Thrombophilia
4. Thrombosis (Thrombus)
5. Thalassemia

Experts

1. Gao, Jian: 1 article (04/2022)
2. Guo, Wenbo: 1 article (04/2022)
3. Wu, Zhiqiang: 1 article (04/2022)
4. Yang, Jianyong: 1 article (04/2022)
5. Zhuang, Wenquan: 1 article (04/2022)
6. Liu, Bangxi: 1 article (03/2022)
7. Luo, Xuefeng: 1 article (03/2022)
8. Wang, Xiaoze: 1 article (03/2022)
9. Zhao, Ming: 1 article (03/2022)
10. Guo, F F: 1 article (02/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cavernous Transformation Of Portal Vein:
1. Lipoprotein(a)IBA
2. Antiphospholipid AntibodiesIBA
3. ThrombinFDA Link
4. Protein CIBA
5. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
6. alpha-Fetoproteins (alpha-Fetoprotein)IBA

Therapies and Procedures

1. Surgical Portasystemic Shunt (Portosystemic Shunt)
2. Transjugular Intrahepatic Portasystemic Shunt
3. Liver Transplantation
4. Operative Surgical Procedures
5. Splenectomy